Phosphorylcholine surface modified flow diverter associated with reduced intimal hyperplasia.
Jildaz CaroffTakamitsu TamuraRobert M KingPedro N LylykErin T LanganOlivia W BrooksFrédéric ClarençonJohn Michael WainwrightLaurent SpelleMiklos MarosfoiMatthew J GounisAjit S PuriPublished in: Journal of neurointerventional surgery (2018)
OCT is a promising technique for immediate and long-term evaluation of flow diverter stent treatments. In an animal model, phosphorylcholine surface modified flow diverters induces less NIH after stent implant without reducing aneurysm occlusion rates.